RareSight is a healthtech start-up on a mission to radically shorten the diagnostic journey for people with rare diseases. Today, patients face an average diagnostic delay of 6-8 years. We believe that’s 6-8 years too long.
Our AI-powered clinical decision support platform helps healthcare professionals detect rare conditions earlier by analyzing complex symptom patterns, integrating clinical data, and surfacing diagnostic suggestions grounded in the latest medical knowledge.
We combine systems biology, machine learning, and clinician-friendly design to empower faster, more accurate diagnoses — and ultimately, better outcomes for patients.
Currently in development, RareSight aims to launch in Switzerland by the end of Q3 2026.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Zurich, Ch
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.rare-sight.com
- Keywords
- London.
- HQ
- Zurich
Raresight Questions
Raresight's website is http://www.rare-sight.com
Raresight's LinkedIn profile is https://ch.linkedin.com/company/raresight
Raresight has
3 employees.
View email and phone details for 3
employees at Raresight.
Raresight's industry is
Hospitals and Health Care
Raresight's top competitors are
Lakeside Pharma Limited,
Autonomous Research,
Nodenza Venture Partners,
Amalgam Rx,
Insight Surgery,
Trade Republic,
Orbimed,
Venturelab.
Raresight's categories are Hospitals and Health Care
Raresight's founding year is 2025
